Generation of mouse UBE2W antibody and analysis of UBE2W expression in mouse tissues

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 24, Issue 4, 2008, Pages 547-552

  Zhang, Yingying ^a   Zhu, Hengqi ^a   Zhao, Lixia ^a   Zhou, Xiaowei ^a   Huang, Peitang ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

Author keywords

Antibody; Tissue expression profile; UBE2W; Ubiquitin conjugating enzyme

Indexed keywords

ESCHERICHIA COLI; MURINAE; ORYCTOLAGUS CUNICULUS; VERTEBRATA;

ANTIBODY; HYBRID PROTEIN; MONOCLONAL ANTIBODY; UBIQUITIN CONJUGATING ENZYME;

ANIMAL; ARTICLE; BIOSYNTHESIS; ESCHERICHIA COLI; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MOUSE; RABBIT; TESTIS; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; ESCHERICHIA COLI; MALE; MICE; RABBITS; RECOMBINANT FUSION PROTEINS; TESTIS; TISSUE DISTRIBUTION; UBIQUITIN-CONJUGATING ENZYMES;

EID: 69849113876     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Smalle J, Vierstra RD. The ubiquitin 26S proteasome proteolytic pathway. Annu Rev Plant Biol, 2004, 55: 555-590.
2. Sun LJ, Chen ZJ. The novel functions of ubiquitination in signaling. Cell Biology, 2004, 16: 119-126.
3. Pickart CM. Ubiquitin in chains. TIBS, 2000, 25: 544-548.
4. Cheng FK, Cory H, Toyoko T, Karl H, et al. Rad6 plays a role in transcriptional activation through ubiquitylation of histone H2B. Genes and Development, 2004, 18: 184-195.
5. Nandi D, Tahiliani P, Kumar A, Chandu D. The ubiquitin-proteasome system. J Biosci, 2006, 31: 137-155.
6. Hershko A, Ciechanover A, Varshavsky A, et al. The ubiquitin-proteasome. Nat Med, 2000, 6(10): 73-84.
7. Robinson PA, Ardley HC. Ubiquitin-protein ligases. Cell Sci, 2004, 117: 5191-5194.
8. Cook WJ, Jeffrey LC, Sullivan ML, et al. Three dimensional structure of an ubiquitin conjugating enzyme (E2). J Biol Chem, 1992, 267: 15116-15121.
9. Cook WJ, Jeffrey LC, Xu Y, et al. Tertiary structures of class I ubiquitin-conjugating enzymes are highly conserved: crystal structure of yeast Ubc4. J Biol Chem, 1993, 32: 13809-13817.
10. Kolman CJ, Toth J, Gonda DK. Identification of a portable determinant of cell cycle function within the carboxyl- terminal domain of the yeast CDC34 (UBC3) ubiquitin conjugating (E2) enzyme. EMBO J, 1992, 11: 3081-3090.
11. Silver ET, Gwozd TJ, Ptak C, et al. A chimeric ubiquitin conjugating enzyme that combines the cell cycle properties of CDC34 (UBC3) and the DNA repair properties of RAD6 (UBC2): implications for the structure, function, and evolution of the E2s. EMBO J, 1992, 11: 3091-3098.
12. Yang ZY, Edenberg HJ, Davis RL. Isolation of mRNA from specific tissues of Drosophila by mRNA tagging. Nucl Acids Res, 2005, 33: e148.
13. Xu H, Lee SJ, Suzuki, et al. A lysosomal tetraspanin associated with retinal degeneration identified via a genome-wide screen. EMBO J, 2004, 23: 811-822.
14. Ed Harlow, David J. Antibodies, A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 1998, pp. 282-318.
15. Seufert W, Jentsch S. Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective degradation of short- lived and abnormal proteins. EMBO J, 1990, 9: 543-550.
16. Wang RX, Xu JC, Outi Saramäki, et al. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Res, 2004, 64: 1589-1594.
17. Porkka K, Saramäki O, Tanner M, et al. Amplification and overexpression of elongin C gene discovered in prostate cancer by cDNA microarrays. Lab Invest, 2002, 82(5): 629-637.
18. Chen C, Sun X, Guo P, et al. Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer. Oncogene, 2007, 26: 2386-2394.